BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 19948239)

  • 1. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
    Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells.
    Mujoo K; Sharin VG; Bryan NS; Krumenacker JS; Sloan C; Parveen S; Nikonoff LE; Kots AY; Murad F
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18924-9. PubMed ID: 19020077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
    El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
    Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
    Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
    Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
    Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
    Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
    Monfort P; Muñoz MD; Kosenko E; Felipo V
    J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
    Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
    Newton M; Niewczas I; Clark J; Bellamy TC
    Anal Biochem; 2010 Jul; 402(2):129-36. PubMed ID: 20371357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
    J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA; Antunes E; Teixeira CE; De Nucci G
    Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS; Andric SA; Stojilkovic SS
    Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.
    Joshi CN; Martin DN; Fox JC; Mendelev NN; Brown TA; Tulis DA
    J Pharmacol Exp Ther; 2011 Nov; 339(2):394-402. PubMed ID: 21825001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
    J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.